Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...
The complex procedure utilized state-of-the-art robotic-assisted technology combined with customizable implants, a cutting-edge approach that offers unparalleled precision and personalization.